These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 7310623)
1. Disinfectants as an aid for good manufacturing practice in the pharmaceutical industry. Wallhäusser KH J Pharm Belg; 1981; 36(5):283-97. PubMed ID: 7310623 [No Abstract] [Full Text] [Related]
2. Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding. Hyde TD Int J Pharm Compd; 2014; 18(1):46-52. PubMed ID: 24881341 [TBL] [Abstract][Full Text] [Related]
3. International Conference on Harmonisation; guidance on good manufacturing practice for active pharmaceutical ingredients; availability. Notice. Food and Drug Administration, HHS Fed Regist; 2001 Sep; 66(186):49028-9. PubMed ID: 12358036 [TBL] [Abstract][Full Text] [Related]
4. [Manufacturing and control in pharmaceutical industry. Introduction into manufacturing control. Introduction]. Hippenmeier F Pharm Acta Helv; 1972; 47(11):625-8. PubMed ID: 4657531 [No Abstract] [Full Text] [Related]
6. Current good manufacturing practice regulations. Bumiller J Bull Parenter Drug Assoc; 1971; 25(5):222-5. PubMed ID: 5094094 [No Abstract] [Full Text] [Related]
7. When pharmacies cause harm. Jha VM Chest; 2013 Aug; 144(2):717. PubMed ID: 23918132 [No Abstract] [Full Text] [Related]
8. Report on the PQRI impurity characterization and quantification best practices survey. Faustino P; Chan CC; Carrano J; Gosnell M; Gu ZQ; Maule A; Sigvardson K; Zhang YF Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396 [No Abstract] [Full Text] [Related]
9. Need for specific-gravity values in adopting gravimetric measurement in sterile compounding. Roberts PA; Valgus JM; Willoughby IR; Amerine LB Am J Health Syst Pharm; 2017 Jun; 74(12):871-872. PubMed ID: 28596223 [No Abstract] [Full Text] [Related]
10. [Changes in the norms governing practices for the manufacture of pharmaceutical products: implications for the MERCOSUR]. Temprano G; Prats S; Bregni C Boll Chim Farm; 1998 Nov; 137(10):426-38. PubMed ID: 9880947 [TBL] [Abstract][Full Text] [Related]
11. Drug product quality. Exp Med Surg; 1971; 29(1):135-44. PubMed ID: 5147595 [No Abstract] [Full Text] [Related]
12. Current good manufacturing practices for PET drug products in the United States. Swanson D; Graham M; Heinonen TM; Libby P; Mills GQ J Nucl Med; 2009 Aug; 50(8):26N-8N. PubMed ID: 19652213 [No Abstract] [Full Text] [Related]
13. [Practical realization of manufacturing control in Switzerland]. Witschi T Pharm Acta Helv; 1972; 47(11):637-47. PubMed ID: 4657533 [No Abstract] [Full Text] [Related]
14. Good manufacturing in All in One compounding. Delanghe M Nutrition; 1989; 5(5):352-4. PubMed ID: 2520326 [No Abstract] [Full Text] [Related]
15. Anticipated revisions to the current good manufacturing practice regulations. Mitchell CM Bull Parenter Drug Assoc; 1974; 28(3):146-51. PubMed ID: 4845938 [No Abstract] [Full Text] [Related]
16. [Validation of procedure for sterile manufacturing. Simulated distribution in containers, in a sterile area]. Arecco D; Carazzone M; Fava M Boll Chim Farm; 1982 Oct; 121(10):493-502. PubMed ID: 7165749 [No Abstract] [Full Text] [Related]
17. [Maintaining standards of good compounding (N.B.F.)]. Castoldi B; Fumagalli A; Mazzoldi G Boll Chim Farm; 1978 Dec; 117(12):689-99. PubMed ID: 752351 [No Abstract] [Full Text] [Related]